XERS
HealthcareXeris Biopharma Holdings, Inc.
$7.09
$-0.26 (-3.54%)
Jan 5, 2026
Price History (1Y)
Analysis
Xeris Biopharma Holdings, Inc. operates within the healthcare sector and biotechnology industry, employing approximately 394 individuals. The company's market capitalization is $1.18 billion. The company has reported revenue of $266.14 million in the trailing twelve months (TTM), with a gross margin of 84.6% and operating margin of 9.0%. Net income for the TTM was -$15,640,000, resulting in a profit margin of -5.9%. The company's balance sheet shows cash holdings of $91.60 million and debt of $257.65 million. Additionally, Xeris Biopharma Holdings has a return on assets (ROA) of 2.9%. The company's valuation is characterized by a forward P/E ratio of 22.54 and an EV/EBITDA ratio of 49.42. Revenue growth for the year-over-year period was 37.1%, although earnings growth could not be determined due to insufficient data.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Visit website →Key Statistics
- Market Cap
- $1.18B
- P/E Ratio
- N/A
- 52-Week High
- $10.08
- 52-Week Low
- $3.14
- Avg Volume
- 2.46M
- Beta
- 0.94
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 394